Page 295 - Programme book for The International Liver Congress 2015, EASL ILC 2015

P1002 THE HISTOLOGICAL SEVERITY OF NAFLD DETERMINES ePOSTERS
P1003 THE CARDIOVASCULAR RISK AND INSULIN RESISTANCE
P1004 IN METABOLICALLY HEALTHY AND UNHEALTHY
P1005 OVERWEIGHT INDIVIDUALS
P1006 Raluca Pais*, Judith Aron Wisniewsky, Fabio Nascimbeni, Joan Tordjman,
P1007 Pascal Lebray, Frederic Charlotte, Pierre Bedossa, Thierry Poynard,
Karine Clement, Vlad Ratziu, France

NONINVASIVE PREDICTION OF EROSIVE ESOPHAGITIS
USING A CONTROLLED ATTENUATION PARAMETER
(CAP)-BASED RISK ESTIMATION MODEL
Young Eun Chon*, Hyunsoo Chung, Seung Up Kim, Sang Kil Lee,
Kyu Sik Jung, Kwang-Hyub Han, Chae Yoon Chon, South Korea

IMPACT OF AEROBIC EXERCISE IN POSTMENOPAUSAL
WOMEN WITH NONALCOHOLIC FATTY LIVER DISEASE:
A 24 WEEKS RANDOMIZED CLINICAL TRIAL
Rosamar E. Rezende, Sebastiao M. Duarte, Jose Tadeu Stefano,
Luiz A. Perandini, Thalita Dassouki, Ana Lucia Sa-Pinto,
Hamilton Roschel, Bruno Gualano, Denise C. Vezozzo, Flair J. Carrilho,
Claudia P. Oliveira*, Brazil

IS ASPIRIN USE A PROTECTOR FACTOR OF
NONALCOHOLIC FATTY LIVER DISEASE?
Angela Peltec*, Victoria Ivanov, Ghenadii Curocichin, Andrei Munteanu,
Vlada Dumbrava, Republic of Moldova

LIVER IRON CONCENTRATION IN THE METABOLIC
SYNDROME WITH HYPERFERRITINEMIA (DYSMETABOLIC
HYPERFERRITINEMIA). RESULTS FROM A COHORT OF
PATIENTS STUDIED BY MRI
Eva Zapata*, Agustin Castiella, Leire Zubiaurre, Arantxa Iribarren,
Jose M. Alustiza, Emma Salvador, Jose I. Emaparanza, Pedro Otazua,
Spain

H63D/H63D GENOTYPE AND H63D ALLELE PREDISPOSE
PATIENTS WITH HYPERFERRITINEMIA TO DEVELOP
METABOLIC SYNDROME
Eva Zapata*, Agustin Castiella, Maria D. De Juan, Leire Zubiaurre,
Arantxa Iribarren, Pedro Otazua, Spain

Vienna, Austria • April 22–26, 2015 295